# Exenatide for alcohol use disorder: 26-week trial results

Source: https://pepvault.app/research/exenatide-klausen-2022

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Exenatide](https://pepvault.app/research#exenatide)

Randomized trial · people

# Exenatide did not cut heavy drinking days in alcohol use disorder

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this trial, weekly exenatide plus therapy did not reduce heavy drinking overall, though it changed brain responses to alcohol cues and showed a signal in people with obesity.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 127
- **Published:** 2022
- **Journal:** JCI Insight

## What they tested

The team tested whether weekly exenatide lowers the number of heavy drinking days in people seeking treatment for alcohol use disorder.

## How the study was done

A randomized, double-blind, placebo-controlled trial in 127 patients with alcohol use disorder. They received exenatide 2 mg or placebo (a dummy shot) under the skin once weekly for 26 weeks, on top of standard cognitive-behavioral therapy (talk therapy), and a subgroup had brain scans.

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The main outcome, heavy drinking days, did not fall by a statistically significant amount with exenatide versus placebo. On fMRI brain scans, people on exenatide showed significantly weaker reactions to alcohol cues in the ventral striatum and septal area, regions linked to reward and addiction. SPECT scans showed less dopamine transporter availability with exenatide than with placebo. In an exploratory look at patients with obesity (BMI > 30 kg/m2), those on exenatide had significantly fewer heavy drinking days and drank less alcohol overall, and side effects were mostly in the gut.

## What it doesn’t show

The trial missed its main goal in the full group. The brain scans covered only a subgroup, and the benefit in patients with obesity came from an exploratory analysis, so it is a lead rather than a confirmed result.

## The paper

Klausen et al. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight. 2022.

- [PubMed (PMID 36066977)](https://pubmed.ncbi.nlm.nih.gov/36066977/)
- [The paper (DOI 10.1172/jci.insight.159863)](https://doi.org/10.1172/jci.insight.159863)
- [ClinicalTrials.gov (NCT03232112)](https://clinicaltrials.gov/study/NCT03232112)

## The compound

- [Exenatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

## With this study

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Studies

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Liraglutide vs Exenatide](https://pepvault.app/peptides/compare/liraglutide-vs-exenatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Exenatide

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024) Randomized trial · people · 2024
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023) Randomized trial · people · 2023
- [Exenatide: 29.2% spontaneous pregnancy vs 14.7% on metformin in PCOS](https://pepvault.app/research/exenatide-li-2022) Randomized trial · people · 2022
- [Exenatide plus dapagliflozin: UACR fell 39.6% vs 11.0% on placebo](https://pepvault.app/research/exenatide-decrease-2021) Randomized trial · people · 2021
- [Exenatide, alone or with dapagliflozin, improved blood sugar in PCOS](https://pepvault.app/research/exenatide-elkind-hirsch-2021) Randomized trial · people · 2021
- [Exenatide ER: 0.9% HbA1c drop vs 1.5% with semaglutide in SUSTAIN 3](https://pepvault.app/research/exenatide-sustain-3-2018) Randomized trial · people · 2018
- [Every study on Exenatide](https://pepvault.app/research#exenatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Studies

- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Exenatide](https://pepvault.app/peptides/compare/semaglutide-vs-exenatide)
- [Liraglutide vs Exenatide](https://pepvault.app/peptides/compare/liraglutide-vs-exenatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Exenatide](https://pepvault.app/research#exenatide)

## The library

- [Exenatide](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
